Edition:
United States

Profile: IRIDEX Corp (IRIX.A)

IRIX.A on American Stock Exchange

2.55USD
5 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,698
52-wk High
$9.28
52-wk Low
$3.03

IRIDEX Corporation, incorporated on November 21, 1995, is a provider of therapeutic-based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. The Company's ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation. The Company's ophthalmology products are sold in the United States through a direct sales force and internationally through approximately 70 independent distributors in over 100 countries.

The family of IQ products includes IQ 532 and IQ 577 laser photocoagulation systems, and the OcuLight products, including OcuLight TX, OcuLight Symphony (Laser Delivery System), OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. The Company also offers the TxCell Scanning Laser Delivery System, a delivery device for a range of laser photocoagulation procedures by allowing physicians to deliver the laser in a multi-spot scanning mode. The Company's family of laser probes includes a range of products in 20, 23, 25 and 27 gauge for vitreoretinal surgery and the MicroPulse P3 (MP3) and G-Probes for glaucoma surgery. The Company produces laser photocoagulator systems, which are used in the treatment of various sight-threatening eye diseases, which include diseases of retina and glaucoma. The Company provides MicroPulse, which is a method of delivering laser energy using a mode, which chops the continuous wave (CW) beam into short, microsecond long, laser pulses.

Ophthalmic Products

The Company's offerings include a console, which generates laser energy, and a range of interchangeable peripheral delivery devices for use in specific clinical applications. The laser consoles include Cyclo G6 Glaucoma Laser System, Visible (Yellow) Photocoagulator Console, Visible (Green) Photocoagulator Console, Infrared Photocoagulator Consoles, MicroPulse Enabled Consoles and Multi-wavelength Laser System Configurations. The Cyclo G6 is an 810 nanometer (nm), infrared laser designed to treat patients diagnosed with a range of glaucoma disease states. The Company sells Cyclo G6 system with a family of probes that are single-use, including its MicroPulse P3 (MP3) disposable probe that utilizes its MicroPulse technology. Its Q 577 delivers visible (Yellow-577nm) laser light. This product utilizes user interface technology and delivers a 577 wavelength, which is at the peak of oxyhemoglobin absorption and allows ophthalmologists to obtain optimal results with lower power (more tissue sparing) compared with green wavelengths. Its IQ 532, OcuLight TX, GL and GLx Photocoagulators deliver visible (Green-532nm) laser light. The IQ 532 product utilizes a user interface and product platform based on the IQ 577. The OcuLight photocoagulator consoles deliver infrared laser light and is available with output power ranges of over two Watts (OcuLight SL) or of approximately three Watts (OcuLight SLx). MicroPulse mode is offered as an option on its IQ 577, IQ 532 and some of the Company's infrared laser photocoagulator systems.

The Company's ophthalmic delivery devices and other products include MicroPulse P3 Probe, TxCell Scanning Laser Delivery System (TxCell), TruFocus Laser Indirect Ophthalmoscope (LIO), Slit Lamp Adapter (SLA), Operating Microscope Adapter (OMA), EndoProbe, G-Probe, DioPexy Probe, GreenTip Soft Tip Cannula and MoistAir In-Line Air Humidifier. The MP3 Probe is a primary delivery device used in the cyclophotocoagulation procedure to treat various stages of glaucoma. The MP3 Probe utilizes MicroPulse technology, and can be performed on an anesthetized eye in the doctor's office. TxCell allows the physician to perform multi-spot pattern scanning for retinal photocoagulation, laser patterns for tissue-sparing MicroPulse protocols and allows for standard single spot photocoagulation. The SLA adapters allow the physician to utilize a standard slit lamp in both diagnosis and treatment procedures. Its standard SLAs have a single fiber and deliver laser light from a single laser console. The OMA adapters allow the physician to utilize a standard operating microscope in both diagnosis and laser treatment procedures. The EndoProbe fiber optic delivery devices are used for endophotocoagulation, a retinal treatment procedure performed in the hospital operating rooms (OR) or surgery center during a vitrectomy procedure. These sterile disposable probes are available in tapered, angled, stepped, aspirating, illuminating, and adjustable styles.

The EndoProbe is offered in a range of gauges. The G-Probe is used in procedures to treat medically and surgically uncontrolled glaucoma, in various instances replacing cyclocryotherapy (freezing of eye tissues). The G-Probe is a sterile single-use product. The DioPexy Probe is a hand-held instrument, which is used in procedures to treat retinal tears and breaks non-invasively through the sclera as an alternative method of attaching the retina. The GreenTip cannula allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure. The MoistAir Humidifying Chamber connects to the airline and provides humidified air to the eye during fluid air exchange.

Ophthalmology Treatments

The Company has a list of procedures for treating ophthalmic diseases that can be addressed by utilizing its ophthalmic laser systems. The procedures include Retinal Photocoagulation, Grid Retinal Photocoagulation, Focal Retinal Photocoagulation, Pan-Retinal Photocoagulation Vitrectomy Procedure, Trabeculoplasty, MicroPulse Transscleral Cyclophotocoagulation, Iridotomy, MicroPulse Transscleral Cyclophotocoagulation, Transscleral Cyclophotocoagulation, MicroPulse Transscleral Cyclophotocoagulation, Retinopexy Retinal Photocoagulation Vitrectomy Procedure, Transscleral Retinal Photocoagulation, Retinal Photocoagulation, Retinal Photocoagulation and Vitrectomy Procedure. It offers these ophthalmology treatments for a range of conditions, such as age-related Macular Degeneration, Diabetic Retinopathy, Macular Edema, Proliferative, Glaucoma, Retinal Tears and Detachments, Retinopathy of Prematurity, Ocular Tumors and Macular Holes.

The Company competes with Novartis AG, Carl Zeiss Meditec AG, Nidek Co. Ltd, Bausch and Lomb, Topcon Corporation, Ellex Medical Lasers, Ltd., Quantel Medical SA, Lumenis Ltd, Genentech, Regeneron, OSI Pharmaceuticals, Allergan, Alimera Sciences and Valeant Pharmaceuticals.

Company Address

IRIDEX Corp

1212 Terra Bella Ave
MOUNTAIN VIEW   CA   94043-1824
P: +1650.9404700
F: +1650.9404710

Company Web Links